SCHEMBL2938540

SCHEMBL2938540

COc1ccc(CNc2c(C)c(C)c3oc(C)c(-c4ccc(F)cc4)c3c2C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 2/20 0.41
GAA P10253 1/20 0.40
CNR1 P21554 2/20 0.39
CNR2 P34972 2/20 0.39
BCHE P06276 1/20 0.39
POLB P06746 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA13 Q8N1Q1 1/20 0.38
TP53 P04637 1/20 0.38
GPR35 Q9HC97 2/20 0.38
PIM1 P11309 1/20 0.38
RAB9A P51151 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2908635 0.92 THRB (0.36) MAPTMEN1KMT2AGAAPIM1
Hydrochloric Acid SCHEMBL2911758 0.88 MAPT (0.42) MAPTMEN1KMT2ANPC1GAA
SCHEMBL2911517 0.87 NPC1 (0.41) MAPTNPC1GAATP53RAB9A
SCHEMBL2913685 0.86 MAPT (0.38) MAPTMEN1KMT2AGAAPOLB
Hydrochloric Acid SCHEMBL2911475 0.86 NPC1 (0.40) MAPTNPC1GAATP53RAB9A
SCHEMBL2907284 0.85 MEN1 (0.37) MAPTMEN1KMT2ANPC1GAA
Hydrochloric Acid SCHEMBL7662408 0.82 NPC1 (0.40) MAPTNPC1GAATP53RAB9A
SCHEMBL2947795 0.69 ADCY1 (0.44) MAPTMEN1KMT2ANPC1TP53
SCHEMBL4036180 0.68 PTGS2 (0.37) MAPTMEN1KMT2ANPC1GAA
Hydrochloric Acid SCHEMBL4039957 0.67 PTGS2 (0.36) MAPTMEN1KMT2ANPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1481679-B1 ANTIDEPRESSANT TAKEDA PHARMACEUTICAL (JP) 2010-08-25 EP disclosed
US-7750037-B2 Antidepressant TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-07-06 US disclosed
EP-2097407-A1 PYRAZOLE ANALOGS Pfizer Products Inc. (US) 2009-09-09 EP disclosed
EP-1323716-B1 PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS TAKEDA PHARMACEUTICAL (JP) 2009-01-14 EP disclosed
US-20090012081-A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells TAKEDA PHARMACEUTICAL COMPANY LTD. (JP) 2009-01-08 US disclosed
US-7456162-B2 Benzofuran derivatives, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-25 US disclosed
WO-2008065493-A1 PYRAZOLE ANALOGS PFIZER PRODUCTS INC. (US) 2008-06-05 WO disclosed
US-20060241168-A1 Antidepressant OHKAWA SHIGENORI 2006-10-26 US disclosed
US-7101867-B2 Benzofuran derivatives, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-09-05 US disclosed
US-20050187238-A1 Benzofuran derivatives, their production and use OHKAWA SHIGENORI (JP) 2005-08-25 US disclosed
CN-1638763-A antidepressants TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2005-07-13 CN disclosed
US-20050148650-A1 Antidepressant TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-07-07 US disclosed
EP-1481679-A1 ANTIDEPRESSANT Takeda Chemical Industries, Ltd. (JP) 2004-12-01 EP disclosed
EP-1136477-B1 BENZOFURAN DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-03-10 EP disclosed
US-20040034049-A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-02-19 US disclosed
EP-1323716-A1 PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS Takeda Chemical Industries, Ltd. (JP) 2003-07-02 EP disclosed
US-6479536-B1 Benzofuran derivatives, process for the preparation of the same and uses thereof TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-11-12 US disclosed
US-20020160996-A1 Benzofuran derivatives, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2002-10-31 US disclosed
EP-1136477-A1 BENZOFURAN DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148650-A1 Antidepressant AKT1S1, AKT1, AKT2 MAPT 3659/4885MEN1 2613/4885KMT2A 1469/4885
US-20060241168-A1 Antidepressant AKT1S1, AKT1, AKT2 MAPT 3659/4885MEN1 2613/4885KMT2A 1469/4885
US-20090012081-A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells NES, MKI67, CCNO MAPT 4127/4885MEN1 2906/4885KMT2A 1061/4885
US-20050187238-A1 Benzofuran derivatives, their production and use WDR1, WDR82, CBR1 MAPT 1426/4885MEN1 2912/4885KMT2A 2211/4885
US-20040034049-A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells NES, HAT1, PROX1 MAPT 4443/4885MEN1 3718/4885KMT2A 451/4885
US-20020160996-A1 Benzofuran derivatives, their production and use PARK7, WDR1, WHR1 MAPT 813/4885MEN1 3777/4885KMT2A 2045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.